Ischemic Attack, Transient clinical trials

The registry lists 329 studies for Ischemic Attack, Transient across more than 10 countries. 71 are recruiting or about to start. 66 of them are mainly about Ischemic Attack, Transient (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Ischemic Attack, Transient studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 170
Recruiting: 54
Status unknown: 49
Not yet recruiting: 16
Active, not recruiting: 14
Terminated: 14

Phase

Phase 3: 37
Phase 2: 20
Phase 4: 12
Phase 1: 6
Early Phase 1: 1

Where

United States: 88
Canada: 47
China: 42
Germany: 38
France: 32
United Kingdom: 29

Who runs them

University College, London (8) · University of Alberta (7) · Beijing Tiantan Hospital (7) · Sunnybrook Health Sciences Centre (7) · Bayer (6) · VA Office of Research and Development (5) · Universitätsklinikum Hamburg-Eppendorf (4) · National Institute of Neurological Disorders and Stroke (NINDS) (4)

What is being tested here

Drugs under test in Ischemic Attack, Transient studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Aspirin	1	3	4
Clopidogrel	1	2	3
Atorvastatin	1	1	1
Cilostazol	1	1	1
Zastaprazan	1	1	1
Tegoprazan	1	1	1
Semaglutide	1	0	1
Ticagrelor	0	5	5
Rivaroxaban	0	2	3
Dabigatran	0	0	2

Drug classes tested here Statins 2 open · P2Y12 inhibitors 1 open · Factor Xa inhibitors 5

Coming up

7phase 3 studies under way

23studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Nov 2026Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · Phase 3 · Capital Medical University
Jun 2027Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) · Phase 3 · Hanyang University Guri Hospital
Sep 2027Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. · Phase 3 · First Affiliated Hospital of Wannan Medical College
Dec 2026Prospective Italian Validation of SMS in Patients With Suspected Acute Stroke · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Dec 2026Florbetaben for Imaging of Vascular Amyloid · Ottawa Heart Institute Research Corporation
Dec 2026Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium · Bakulev Scientific Center of Cardiovascular Surgery
Dec 2026Digital Application for Stroke Health · VASCage GmbH
Dec 2026COAST Study - Cholesterol Optimization After Stroke · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Dec 2026Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System · Beijing Tiantan Hospital
Jan 2027Diagnosis of Transient Ischemic Attacks in the Emergency Department · University Hospital, Strasbourg, France

Who these studies take

Of the 54 Ischemic Attack, Transient studies recruiting now, 36 (67%) set no upper age limit and 6 (11%) stop at 75 or younger. 6 (11%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (17%) take healthy volunteers.

Recruiting studies that take each age, of 54
Age	Women	Men
10	3 (6%)	3 (6%)
18	40 (74%)	40 (74%)
30	42 (78%)	42 (78%)
40	49 (91%)	49 (91%)
50	50 (93%)	50 (93%)
65	52 (96%)	52 (96%)
75	49 (91%)	49 (91%)
85	42 (78%)	42 (78%)

Across all 329 studies, recruiting or not: 8% stop at 75 or younger and 5% at 65; 12% take children; 0% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ischemic Attack, Transient studies take

Of 13 phase 3 interventional studies under Ischemic Attack, Transient, half reached primary completion within 32 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 3	32 mo22–51 · 13 studies	—	—
Interventional, no phase	46 mo23–72 · 71 studies	—	48 mo24–72 · 64 studies
Observational	49 mo22–92 · 75 studies	—	52 mo22–101 · 71 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 329. Browse all 329 → or search them.